Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-12-14-Speech-1-046"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2009-12-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:One-minute speeches on matters of political importance2
dcterms:Language	"es"^^xsd:language2
lpv:document identification number	"en.20091214.14.1-046"2
lpv:hasSubsequent	lp_eu:2009-12-14-Speech-1-0472
lpv:speaker	lp:Teresa Riera Madurell2
lpv:spokenAs	unknown; Partido Socialista Obrero Español (2009-07-14--2014-06-30)3 substitute; AFET (2009-07-16--2012-01-18)3 member; ITRE (2009-07-16--2012-01-18)3 member; Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN) (2009-09-16--2014-06-30)3 substitute; SEDE (2009-07-16--2012-01-18)3 member; S&D (2009-07-14--2014-06-30)3 substitute; Delegation to the EU-Armenia, EU-Azerbaijan and EU-Georgia Parliamentary Cooperation Committees (2009-09-16--2014-06-30)3 member; Delegation for relations with the NATO Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2011-05-08)3
lpv:translated text	"Mr President, clinical trials are a benchmark method of clinical research and are considered to be the most reliable source of information on which to base treatment decisions. I would, however, like to alert the House to the fact that a recent study by the European Society of Cardiology has once again demonstrated that there are serious limitations to this methodology as a result of low levels of participation by women in such trials. The differences between men and women, in terms of risk factors, disease presentation and response to treatment have been scientifically proven. The result is that the spectacular achievements in recent years in terms of prevention and treatment of cardiovascular diseases have not been reflected in a significant decline in women’s mortality rates. It is therefore essential that as European institutions, we promote research that is specifically aimed at women, either through their more extensive inclusion in clinical studies, or through designing studies that are conducted exclusively on women."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph